Quoin Pharmaceuticals
QNRX
4 hedge funds and large institutions have $664K invested in Quoin Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
0% less ownership
Funds ownership: 0% → 0% (-0%)
30% less capital invested
Capital invested by funds: $949K → $664K (-$285K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$116K |
| 2 |
HF
HRT Financial
New York
|
+$57.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$116K |
| 2 |
Citigroup
New York
|
-$1K |
| 3 |
PA
Procyon Advisors
Shelton,
Connecticut
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $466K | -$116K | -2 | -15% |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $84K | +$116K | +2 | New |
|
|
HF
3
HRT Financial
New York
| $56K | +$57.8K | +1 | New |
|
4
UBS Group
Zurich,
Switzerland
| $34K | – | – | – |
|
5
Morgan Stanley
New York
| $22K | – | – | – |
|
|
ASN
6
Advisory Services Network
Atlanta,
Georgia
| $2K | – | – | – |
|
|
7
Citigroup
New York
| – | -$1K | – | – |
|
|
PA
8
Procyon Advisors
Shelton,
Connecticut
| – | -$1K | – | – |
|
QNRX Hedge Fund Activity: Q3 2020 in Review
4 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2020, worth a combined $664K — down 30% from $949K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new QNRX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Wedbush Securities, opening a new position worth an estimated $116K. The largest seller was Renaissance Technologies, cutting an estimated $116K.
- 4 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q3 2020, up from 2 in Q2 2020.
- Funds reported $664K of Quoin Pharmaceuticals stock for Q3 2020, down 30% quarter-over-quarter.
- 2 funds opened new Quoin Pharmaceuticals positions in Q3 2020 and 0 closed out, a net change of +2 holders.
- The largest Quoin Pharmaceuticals buyer in Q3 2020 was Wedbush Securities, an estimated $116K added.
- The largest Quoin Pharmaceuticals seller in Q3 2020 was Renaissance Technologies, an estimated $116K sold.
Based on aggregated 13F filings for Q3 2020.